<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="The LBT06 table produces the standard laboratory abnormalities by visit and
baseline status summary."><title>LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. — lbt06_main • chevron</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.2.2/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.2.2/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. — lbt06_main"><meta property="og:description" content="The LBT06 table produces the standard laboratory abnormalities by visit and
baseline status summary."><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--><link rel="stylesheet" href="../consent.css"><script src="../consent.js" type="text/javascript" charset="utf-8"></script></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">chevron</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.2.0.9000</small>

    <div style="width: 140px; margin-left: 0.5rem;"> <small class="nav-text text-muted me-auto">part of</small> <img src="https://github.com/insightsengineering/hex-stickers/blob/main/PNG/nest.png?raw=true" alt="NEST" style="height: 30px;"><a href="https://pharmaverse.org/" class="external-link"><img src="https://github.com/insightsengineering/hex-stickers/blob/main/PNG/pharmaverse.png?raw=true" alt="pharmaverse" style="height: 28px;"></a> </div>
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="nav-item">
  <a class="nav-link" href="../articles/chevron.html">Get started</a>
</li>
<li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="../articles/index.html">Articles</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
<!-- start dropdown for versions --> <li class="nav-item dropdown">
        <a href="#" class="nav-link dropdown-toggle"
          data-bs-toggle="dropdown" role="button"
          aria-expanded="false" aria-haspopup="true"
          id="dropdown-versions">Versions</a> <div class="dropdown-menu" aria-labelledby="dropdown-versions"> <a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/main">main</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/latest-tag">latest-tag</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.0">v0.2.0</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.4">v0.1.4</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.3">v0.1.3</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.2">v0.1.2</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.1">v0.1.1</a> </div></li>
<!-- end dropdown for versions -->
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-reports">Reports</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-reports">
    <a class="dropdown-item" href="../coverage-report/">Coverage report</a>
    <a class="dropdown-item" href="../unit-test-report/">Unit test report</a>
  </div>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/insightsengineering/chevron">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1><code>LBT06</code> Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1.</h1>
      
      <div class="d-none name"><code>lbt06.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The <code>LBT06</code> table produces the standard laboratory abnormalities by visit and
baseline status summary.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">lbt06_main</span><span class="op">(</span><span class="va">adam_db</span>, arm_var <span class="op">=</span> <span class="st">"ACTARM"</span>, <span class="va">...</span><span class="op">)</span></span>
<span></span>
<span><span class="fu">lbt06_pre</span><span class="op">(</span><span class="va">adam_db</span>, <span class="va">...</span><span class="op">)</span></span>
<span></span>
<span><span class="fu">lbt06_post</span><span class="op">(</span><span class="va">tlg</span>, prune_0 <span class="op">=</span> <span class="cn">FALSE</span>, <span class="va">...</span><span class="op">)</span></span>
<span></span>
<span><span class="va">lbt06</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="format">Format<a class="anchor" aria-label="anchor" href="#format"></a></h2>
    <p>An object of class <code>chevron_t</code> of length 1.</p>
    </div>
    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>
    <dl><dt>adam_db</dt>
<dd><p>(<code>list</code> of <code>data.frames</code>) object containing the <code>ADaM</code> datasets</p></dd>


<dt>arm_var</dt>
<dd><p>(<code>string</code>) the arm variable used for arm splitting.</p></dd>


<dt>...</dt>
<dd><p>not used.</p></dd>


<dt>tlg</dt>
<dd><p>(<code>TableTree</code>, <code>Listing</code> or <code>ggplot</code>) object typically produced by a <code>main</code> function.</p></dd>


<dt>prune_0</dt>
<dd><p>(<code>flag</code>) remove 0 count rows</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="details">Details<a class="anchor" aria-label="anchor" href="#details"></a></h2>
    
<ul><li><p>Only count <code>"LOW"</code> or <code>"HIGH"</code> values for <code>ANRIND</code> and <code>BNRIND</code>.</p></li>
<li><p>Lab test results with missing <code>ANRIND</code> values are excluded.</p></li>
<li><p>Split columns by arm, typically <code>ACTARM</code>.</p></li>
<li><p>Keep zero count rows by default.</p></li>
</ul></div>
    <div class="section level2">
    <h2 id="functions">Functions<a class="anchor" aria-label="anchor" href="#functions"></a></h2>
    
<ul><li><p><code>lbt06_main()</code>: Main TLG function</p></li>
<li><p><code>lbt06_pre()</code>: Preprocessing</p></li>
<li><p><code>lbt06_post()</code>: Postprocessing</p></li>
</ul></div>
    <div class="section level2">
    <h2 id="note">Note<a class="anchor" aria-label="anchor" href="#note"></a></h2>
    
<ul><li><p><code>adam_db</code> object must contain an <code>adlb</code> table with columns <code>"AVISIT"</code>, <code>"ANRIND"</code>, <code>"BNRIND"</code>,
<code>"ONTRTFL"</code>, and <code>"PARCAT2"</code>, and column specified by <code>arm_var</code>.</p></li>
</ul></div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="fu"><a href="run.html">run</a></span><span class="op">(</span><span class="va">lbt06</span>, <span class="va">syn_data</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   Parameter                                                                            </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     Visit                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Abnormality at Visit                  A: Drug X      B: Placebo    C: Combination</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>               Baseline Status                (N=134)        (N=134)         (N=132)    </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   —————————————————————————————————————————————————————————————————————————————————————</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   Alanine Aminotransferase Measurement                                                 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 1 DAY 8                                                                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    3/39 (7.7%)     2/40 (5%)      1/37 (2.7%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status         1/4 (25%)         0/2             0/7      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      4/43 (9.3%)    2/42 (4.8%)     1/44 (2.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   3/42 (7.1%)    3/35 (8.6%)     4/41 (9.8%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/1            0/7             0/3      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                       3/43 (7%)     3/42 (7.1%)     4/44 (9.1%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 2 DAY 15                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    5/29 (17.2%)   2/30 (6.7%)     7/45 (15.6%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status         1/2 (50%)         0/5             0/7      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      6/31 (19.4%)   2/35 (5.7%)     7/52 (13.5%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   1/26 (3.8%)    4/33 (12.1%)    4/45 (8.9%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/5            0/2         1/7 (14.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      1/31 (3.2%)    4/35 (11.4%)    5/52 (9.6%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 3 DAY 22                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    2/34 (5.9%)    3/34 (8.8%)     1/35 (2.9%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status        1/3 (33.3%)        0/0          1/4 (25%)   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      3/37 (8.1%)    3/34 (8.8%)     2/39 (5.1%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   5/33 (15.2%)   5/29 (17.2%)    3/34 (8.8%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status        1/4 (25%)         0/5             0/5      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      6/37 (16.2%)   5/34 (14.7%)    3/39 (7.7%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 4 DAY 29                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status     2/40 (5%)     2/39 (5.1%)     1/38 (2.6%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status            0/2         1/4 (25%)          0/5      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      2/42 (4.8%)     3/43 (7%)      1/43 (2.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   5/36 (13.9%)   1/34 (2.9%)     6/39 (15.4%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status       1/6 (16.7%)    1/9 (11.1%)         0/4      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      6/42 (14.3%)   2/43 (4.7%)      6/43 (14%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 5 DAY 36                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    2/35 (5.7%)    6/35 (17.1%)    4/44 (9.1%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status        1/3 (33.3%)     2/8 (25%)          0/3      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      3/38 (7.9%)    8/43 (18.6%)    4/47 (8.5%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   4/38 (10.5%)   7/38 (18.4%)    1/41 (2.4%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/0            0/5             0/6      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      4/38 (10.5%)   7/43 (16.3%)    1/47 (2.1%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   C-Reactive Protein Measurement                                                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 1 DAY 8                                                                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    4/46 (8.7%)     2/40 (5%)      4/42 (9.5%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status            0/5            0/2             0/2      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      4/51 (7.8%)    2/42 (4.8%)     4/44 (9.1%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   6/44 (13.6%)   4/37 (10.8%)    1/35 (2.9%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/7         1/5 (20%)          0/9      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      6/51 (11.8%)   5/42 (11.9%)    1/44 (2.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 2 DAY 15                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    4/39 (10.3%)   3/29 (10.3%)    2/33 (6.1%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status        1/3 (33.3%)        0/2             0/3      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      5/42 (11.9%)   3/31 (9.7%)     2/36 (5.6%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   2/36 (5.6%)    3/27 (11.1%)    3/27 (11.1%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/6         1/4 (25%)          0/9      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      2/42 (4.8%)    4/31 (12.9%)    3/36 (8.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 3 DAY 22                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    3/37 (8.1%)     6/46 (13%)     8/44 (18.2%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status            0/3            0/5             0/6      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      3/40 (7.5%)    6/51 (11.8%)     8/50 (16%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   2/34 (5.9%)    2/44 (4.5%)     1/43 (2.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/6            0/7             0/7      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                       2/40 (5%)     2/51 (3.9%)      1/50 (2%)   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 4 DAY 29                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    3/42 (7.1%)    1/36 (2.8%)     4/34 (11.8%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status            0/4         1/2 (50%)          0/5      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      3/46 (6.5%)    2/38 (5.3%)     4/39 (10.3%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   3/40 (7.5%)    1/35 (2.9%)     5/34 (14.7%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status       1/6 (16.7%)    1/3 (33.3%)         0/5      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      4/46 (8.7%)    2/38 (5.3%)     5/39 (12.8%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 5 DAY 36                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    5/34 (14.7%)   4/38 (10.5%)    5/41 (12.2%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status        1/6 (16.7%)        0/4          1/5 (20%)   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                       6/40 (15%)    4/42 (9.5%)      6/46 (13%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   4/35 (11.4%)   4/35 (11.4%)    3/39 (7.7%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/5            0/7         1/7 (14.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                       4/40 (10%)    4/42 (9.5%)     4/46 (8.7%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   Immunoglobulin A Measurement                                                         </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 1 DAY 8                                                                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    2/38 (5.3%)    3/38 (7.9%)      3/30 (10%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status        1/7 (14.3%)     1/4 (25%)       1/4 (25%)   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      3/45 (6.7%)    4/42 (9.5%)     4/34 (11.8%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   2/38 (5.3%)    3/37 (8.1%)     1/30 (3.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status       2/7 (28.6%)     1/5 (20%)       1/4 (25%)   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      4/45 (8.9%)    4/42 (9.5%)     2/34 (5.9%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 2 DAY 15                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    2/36 (5.6%)    5/45 (11.1%)    5/43 (11.6%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status         1/4 (25%)         0/4         1/6 (16.7%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      3/40 (7.5%)    5/49 (10.2%)    6/49 (12.2%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   7/39 (17.9%)   4/44 (9.1%)     5/46 (10.9%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/1            0/5             0/3      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      7/40 (17.5%)   4/49 (8.2%)     5/49 (10.2%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 3 DAY 22                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    7/43 (16.3%)    4/40 (10%)     2/38 (5.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status            0/5            0/10         2/4 (50%)   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      7/48 (14.6%)    4/50 (8%)      4/42 (9.5%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   2/41 (4.9%)    5/48 (10.4%)    5/36 (13.9%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/7            0/2             0/6      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      2/48 (4.2%)     5/50 (10%)     5/42 (11.9%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 4 DAY 29                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    2/29 (6.9%)    7/43 (16.3%)    4/46 (8.7%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status            0/5            0/10            0/2      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      2/34 (5.9%)    7/53 (13.2%)    4/48 (8.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   6/29 (20.7%)   4/49 (8.2%)     3/44 (6.8%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/5         1/4 (25%)       1/4 (25%)   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      6/34 (17.6%)   5/53 (9.4%)     4/48 (8.3%)  </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     WEEK 5 DAY 36                                                                      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       Low                                                                              </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not low baseline status    4/41 (9.8%)    6/39 (15.4%)    5/38 (13.2%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Low baseline status            0/2            0/5             0/2      </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                      4/43 (9.3%)    6/44 (13.6%)    5/40 (12.5%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       High                                                                             </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Not high baseline status   3/37 (8.1%)    5/39 (12.8%)    4/38 (10.5%) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 High baseline status           0/6            0/5          1/2 (50%)   </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 Total                       3/43 (7%)     5/44 (11.4%)    5/40 (12.5%) </span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="nest">
  <p>chevron is a part of the <strong>NEST</strong> and <a href="https://pharmaverse.org/" class="external-link"><strong>pharmaverse</strong></a>.</p>
</div>
<script type="text/javascript" src="../analytics.js"></script></footer></div>

  

  

  </body></html>

